Sysmex

Basic Information

Stock Code
6869
Industry
Electrical Equipment
Category Detail
Biotechnology & Pharmaceuticals
Prefecture
Hyogo Prefecture
Establishment Year
February 1968
Listing Year
November 1995
Official Website
https://www.sysmex.co.jp/
TSE Information
TSE Information
Yahoo! Finance
Yahoo! Finance
Other Companies
Towns, Atect, Terumo, Eiken Chemical, Kainos, Immuno-Biological Laboratories, Mizuho Medy, Asahi Intecc, Unicharm

Overview

Sysmex is a medical equipment manufacturer founded in 1968, recognized as a global leader in in vitro diagnostic equipment with a wide product lineup and global presence.

Current Situation

Sysmex achieved consolidated net sales of ¥508.6 billion, operating income of ¥87.6 billion, and net income of ¥53.7 billion for the fiscal year ending March 2025, with overseas sales accounting for over 80% as a global company. It holds the world's top market share in its core fields of hematology, hemostasis, and urinalysis, offering a wide range of testing instruments and reagents. In recent years, it has focused on genetic testing and regenerative medicine, acquiring startups as subsidiaries and entering the medical robot business to diversify operations. It plans to relocate its head office to a new office in central Kobe in 2028, strengthening its R&D environment. The company emphasizes quality control and corporate governance, focusing on sustainable growth and innovation. Recently, it has accelerated capital alliances and technology investments, aiming for global deployment of innovative medical technologies by 2030.

Trivia

Interesting Facts

  • Holds top global share in in vitro diagnostic equipment.
  • Founded in 1968, a pioneering company in medical equipment.
  • Entered medical robot development via joint venture with Kawasaki Heavy Industries.
  • Owns large-scale research institute and factory in Nishi-ku, Kobe.
  • Blood analyzer market share highly rated in over 80 countries worldwide.
  • Pioneer in regenerative medicine with university-launched venture subsidiaries.
  • Engages in multifaceted sponsorship of top athletes.
  • Maintains strict proprietary standards for reagent and consumable quality control.
  • Developed inspection systems awarded Good Design Gold Award.
  • Past undeclared income issues, but ongoing governance enhancements implemented.

Hidden Connections

  • Focuses on medical robot business through joint venture Medicaroid with Kawasaki Heavy Industries.
  • Builds reagent supply network through alliances with numerous pharmaceutical-related companies.
  • Contributes to region as official partner of local sports teams.
  • Accelerates market entry of regenerative medicine technologies via university startups.
  • Multinational company providing products across wide testing fields in Japan and abroad.
  • Collaborates with IT companies for service development to promote medical DX.
  • Participates in urban redevelopment projects as a local Kobe company.
  • Maintains cooperative relationships with diverse logistics companies for mass production of testing equipment.

Future Outlook

Growth Drivers

  • Market expansion in regenerative medicine and genetic testing
  • Increasing global demand for medical equipment
  • Expectations for improved testing efficiency via medical DX
  • Growth and technological innovation in medical robot market
  • Enhanced presence in overseas emerging markets
  • Ongoing development of advanced testing technologies
  • Flexible response to diverse medical needs
  • Market expansion for testing equipment due to regulatory easing
  • Brand value enhancement through environmentally and socially conscious management
  • Service diversification through strengthened IT collaborations

Strategic Goals

  • Establish genetic testing and regenerative medicine as core businesses
  • Achieve over 90% overseas sales ratio
  • Enter world top class in medical robots market
  • Achieve sustainable product development and carbon neutrality
  • Advanced customer services through DX promotion
  • Realize over ¥100 billion in new business sales
  • Strengthen global talent through diversity initiatives
  • Global unification of advanced quality management systems
  • Innovative technology development through enhanced academic collaborations
  • Expand market share in smart testing equipment

Business Segments

In Vitro Diagnostic Equipment Sales

Overview
Provides sales, maintenance services for cutting-edge testing equipment and reagents to medical institutions, supporting reliable testing environments.
Competitiveness
Local support capabilities through global network
Customers
  • Hospitals
  • Clinics
  • Clinical Laboratories
  • Public Health Laboratories
  • Veterinary Facilities
  • Pharmaceutical Companies
Products
  • Hematology Analyzers
  • Hemostasis Analyzers
  • Urinalysis Systems
  • Immunoassay Analyzers
  • Reagents
  • Consumables

Regenerative Medicine & Biotechnology

Overview
Provides R&D support equipment and technology services for advanced regenerative medicine and genetics.
Competitiveness
Technology development through collaborations with university-launched ventures
Customers
  • University Research Institutions
  • Biotech Ventures
  • Pharmaceutical Companies
  • Medical Institutions
Products
  • Cell Culture Systems
  • Genetic Testing Solutions
  • Biotech Reagents
  • Cell Therapy Products

Medical IT & Services

Overview
Provides IT solutions to centralize test data management and improve operational efficiency, promoting medical DX.
Competitiveness
Customized solutions based on extensive testing expertise
Customers
  • Medical Institutions
  • Testing Centers
  • Regional Medical Collaboration Organizations
Products
  • Laboratory Information Management Systems
  • Cloud Services
  • RPA Solutions

Medical Robot Business

Overview
Supports technological innovation in medical settings through advanced surgical support robots and maintenance.
Competitiveness
Powerful technology integration with Kawasaki Heavy Industries
Customers
  • General Hospitals
  • Surgical Clinics
  • Medical Equipment Distributors
Products
  • Surgical Support Robots
  • Surgical Peripheral Devices
  • Maintenance Services

Reagents & Consumables Manufacturing

Overview
Manufactures and supplies high-quality, reliable reagents and consumables, contributing to improved testing accuracy.
Competitiveness
Strict quality control systems domestically and internationally
Customers
  • Medical Institutions
  • Testing Equipment Manufacturers
  • Research Institutions
Products
  • Testing Reagents
  • Diagnostic Drugs
  • Testing-Related Consumables

Overseas Operations

Overview
Operates in over 190 countries worldwide, providing products and services tailored to local needs.
Competitiveness
Over 80% overseas sales ratio and multinational structure
Customers
  • Overseas Medical Institutions
  • Distributors
  • Local Sales Companies
Products
  • Testing Equipment
  • Reagents
  • Maintenance Support Services

Competitive Advantage

Strengths

  • Business operations in over 190 countries worldwide
  • World's top market share in hematology analyzers
  • High R&D capabilities and extensive product lineup
  • Global expansion powered by over 80% overseas sales
  • Joint venture with Kawasaki Heavy Industries in medical robots
  • Long-term trusted relationships with customers
  • Robust quality control and corporate governance
  • Diverse product portfolio across testing fields
  • Focus on advanced genetic testing and regenerative medicine
  • Comprehensive customer support through extensive service network
  • Technological innovation through startup collaborations

Competitive Advantages

  • Maintains world No.1 position in hemostasis and urinalysis
  • Enhanced local support leveraging global network
  • Risk diversification through diverse product portfolio
  • Integration of advanced analytics and medical devices
  • Advanced technology and strengthened partnerships in medical robots
  • Acquisition of cutting-edge technologies via university ventures
  • Improved diagnostic accuracy through proprietary blood testing technology
  • Continuous attainment of international sustainability ratings
  • Flexibility and responsiveness to diverse medical markets
  • Reliability ensured by advanced quality assurance systems
  • Aggressive overseas market development and new customer acquisition
  • Medical DX promotion through IT solutions

Threats

  • Rise of competitors in emerging markets
  • Risk of lagging behind rapid technological advancements
  • Business constraints from stricter regulations
  • Declining profit margins due to intensified price competition
  • Revenue impacts from exchange rate fluctuations
  • Market volatility risks from new infectious diseases
  • Patent infringements and intellectual property risks
  • Supply chain disruption risks
  • Decline in competitiveness due to shortage of highly skilled talent
  • Stricter safety regulations for medical devices

Innovations

2024: Plan to Relocate Head Office to Sannomiya, Kobe

Overview
Relocating head office functions to central Kobe in spring 2028 to strengthen research environment.
Impact
Improved R&D efficiency and organizational collaboration

2023: Subsidiary Acquisition of Regenerative Medicine Venture 'Megakaryon'

Overview
Acquired university-launched startup to gain mass production technology for platelets using iPS cells.
Impact
Expansion in next-generation medicine

2022: Medical Surgical Support Robot Technology Development

Overview
Jointly developing medical robot business with Kawasaki Heavy Industries, establishing advanced surgical support technology.
Impact
Strengthened foundation for global market entry

2021: Expansion of HISCL Series Immunoagglutination Analyzers

Overview
Expanded lineup of high-sensitivity immunoassay analyzers for cancer testing and more.
Impact
Improved testing accuracy and scope of application

2025: Development of Cloud System for Test Data Management

Overview
Providing cloud-based IT solutions to streamline laboratory information management for medical institutions.
Impact
Operational efficiency and medical DX promotion

Sustainability

  • Development of energy-efficient products to reduce environmental impact
  • Introduction of sustainable supply chain management
  • Promotion of fair talent utilization and diversity policies
  • Ongoing active contributions to local communities
  • Business operations compliant with international environmental standards
  • Ensuring safe work environments and improving employee satisfaction
  • Promotion of product recycling and waste reduction measures
  • Strengthening corporate ethics and compliance
  • Development of sustainable medical device manufacturing technologies
  • Initiatives toward carbon neutrality goals